germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Fundació</strong> <strong>Institut</strong> <strong>d'Investigació</strong><br />
<strong>en</strong> <strong>Ciències</strong> <strong>de</strong> la Salut<br />
Germans Trias i Pujol<br />
compound <strong>en</strong>dowed with anti‐HIV‐1 activity.<br />
J CHEM INF MODEL 2006; 46(3):1344‐1351.<br />
3,423<br />
Martinez‐Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, Thobakgale C, Honeyborne I, Crawford H, Matthews P, Pillay<br />
T, Rousseau C, Mullins JI, Bran<strong>de</strong>r C, Walker BD, Stuart DI, Kiepiela P, Goul<strong>de</strong>r P.<br />
Fitness cost of escape mutations in p24 Gag in association with control of human immuno<strong>de</strong>fici<strong>en</strong>cy virus type 1.<br />
J VIROL 2006; 80(7):3617‐3623.<br />
5,341<br />
May MT, Sterne JA, Costagliola D, Sabin CA, Phillips AN, Justice AC, Dabis F, Gill J, Lundgr<strong>en</strong> J, Hogg RS, <strong>de</strong> Wolf F, Fatk<strong>en</strong>heuer<br />
G, Staszewski S, d'Arminio Monforte A, Egger M; Antiretroviral Therapy (ART) Cohort Collaboration.<br />
HIV treatm<strong>en</strong>t response and prognosis in Europe and North America in the first <strong>de</strong>ca<strong>de</strong> of highly active antiretroviral therapy: a<br />
collaborative analysis.<br />
LANCET 2006 Aug 5;368(9534):451‐8<br />
25,8<br />
Mocroft A, Neaton J, Bebchuk J, Staszewski S, Antunes F, Knysz B, Law M, Phillips AN, Lundgr<strong>en</strong> JD; EuroSIDA Study Group; ESPRIT<br />
Study Group.<br />
The feasibility of clinical <strong>en</strong>dpoint trials in HIV infection in the highly active antiretroviral treatm<strong>en</strong>t (HAART) era.<br />
Clin Trials 2006; 3(2):119‐32<br />
Mocroft A, Phillips AN, Le<strong>de</strong>rgerber B, Katlama C, Chiesi A, Goebel FD, Knysz B, Antunes F, Reiss P, Lundgr<strong>en</strong> JD.<br />
Relationship betwe<strong>en</strong> antiretrovirals used as part of a cART regim<strong>en</strong> and CD4 cell count increases in pati<strong>en</strong>ts with suppressed<br />
viremia.<br />
AIDS 2006 May 12;20(8):1141‐50<br />
5,632<br />
Mocroft A, Rockstroh J, Soriano V, Kirk O, Viard JP, Caplinskas S, Gasiorowski J, Chiesi A, Phillips AN, Lundgr<strong>en</strong> JD, EuroSIDA<br />
Study Group.<br />
Limited but increasing use of treatm<strong>en</strong>t for hepatitis C across Europe in pati<strong>en</strong>ts coinfected with HIV and hepatitis C.<br />
SCAND J INFECT DIS 2006;38(11‐12):1092‐7<br />
1,56<br />
Molto J, Blanco A, Miranda C, Miranda J, Puig J, Valle M, DelaVarga M, Fumaz CR, Barbanoj MJ, Clotet B.<br />
Variability in non‐nucleosi<strong>de</strong> reverse transcriptase and protease inhibitor conc<strong>en</strong>trations among HIV‐infected adults in routine<br />
clinical practice.<br />
BRIT J CLIN PHARMACO 2006; 62(5):560‐566.<br />
2,718<br />
Pàgina 124/177
Change language